Goldman Sachs’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-110,000
Closed -$1.73M 6018
2022
Q3
$1.73M Hold
110,000
﹤0.01% 4090
2022
Q2
$2.77M Buy
+110,000
New +$3.29M ﹤0.01% 3750

Other funds holding CRNC

Goldman Sachs's CRNC Position: Q1 2026 in Review

Goldman Sachs increased its Cerence (CRNC) stake by 36% in Q1 2026, buying an estimated $2.62M and bringing the position to 1,090,599 shares worth $6.88M. The position accounts for ﹤0.01% of the portfolio, ranked #3386.

Goldman Sachs first reported a position in CRNC in Q4 2019 and has held it in 26 quarters since. The position peaked at $61.9M in Q2 2021. 195 funds tracked by Wall St. Rank hold CRNC as of Q1 2026.

  • Goldman Sachs held 1,090,599 shares of Cerence worth $6.88M as of Q1 2026.
  • Goldman Sachs bought 290,823 Cerence shares in Q1 2026, an estimated $2.62M.
  • Cerence made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #3386 holding.
  • Goldman Sachs first reported a position in Cerence in Q4 2019 and has held it in 26 quarters since.
  • Goldman Sachs's Cerence position peaked at $61.9M in Q2 2021.
  • 195 funds tracked by Wall St. Rank held Cerence as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.